Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Ankit Singhal
Ankit is the CEO of Anthrogen. He was a Science Research Fellow and Named Scholar at Columbia (a designation reserved for the top ~10 STEM research students in each class). He has worked in both wet labs and computational labs (focusing on catalysis and structural biology/biophysics) for years. He published several first-author papers as early as high school, won and led national teams at international science/research competitions – he’s excited to lead Anthrogen’s damp lab approach.
Companies & Work
Anthrogen
Proteins power everything from the cells in your body to creating materials you rely on every day—but until now, we’ve been forced to discover their functions by trial and error. Designing a new therapeutic can take decades and billions of dollars, and even our best industrial catalysts work at a snail’s pace compared to their theoretical optimums.
Anthrogen is changing that. By training massive AI foundation models on protein sequences and structures, we’ve unlocked the ability to generate—on demand—completely novel molecular machines with atomic-level precision. Simply describe the function you need, and our platform imagines the peptide or protein that will deliver it.
We're building models to speed up billions of years of evolution into the span of an afternoon's worth of compute.
The result? New-to-nature therapies, ultra-efficient catalysts for sustainable manufacturing, and a whole new frontier of molecular innovation—designed as precisely as any cutting-edge aircraft or microchip.
Anthrogen is changing that. By training massive AI foundation models on protein sequences and structures, we’ve unlocked the ability to generate—on demand—completely novel molecular machines with atomic-level precision. Simply describe the function you need, and our platform imagines the peptide or protein that will deliver it.
We're building models to speed up billions of years of evolution into the span of an afternoon's worth of compute.
The result? New-to-nature therapies, ultra-efficient catalysts for sustainable manufacturing, and a whole new frontier of molecular innovation—designed as precisely as any cutting-edge aircraft or microchip.
